Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Substituted-iminodiacids-their-preparation-and-pharmaceutical-compositions-containing-them

 Therapeutic compositions with enhanced bioavailability
OF THE INVENTION This invention relates to compositions of a drug with a water soluble polymer ...


 Medicament adsorbates and their preparation
In particular, it has been found that a good tasting medicament adsorbate is produced from ...


 Sustained release formulations
We claim: 1. In combination, a drug suitable for oral delivery and a delivery system for sustained ...


 Water dispersible gemfibrozil compositions
What is claimed is: 1. A water-dispersible formulation of gemfibrozil comprising finely divided ...


 Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
OF SPECIFIC EMBODIMENTS In accordance with this invention, tyrosine or a tyrosine precursor such ...


 1-azabicycloalkane derivatives, their preparation process and their use as medicaments
What is claimed is: 1. A compound of formula (I) ##STR5## in which n represents the number 1, R.sub....


 Use of specific N-methyl-D-aspartate receptor antagonists in the prevention and treatment of neurodegeneration
OF THE INVENTION The novel method of treatment of neurodegeneration of this invention comprises ...


 Iron citrate complex, process for its production, and its pharmaceutical
We claim: 1. An iron citrate micellar complex, which is a brown solid having the properties set out ...


 Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same
OF INVENTION The 4,5-bis(4-methoxyphenyl)-2-(pyrrol-2-yl)thiazoles of the present invention have ...


 Specifically .beta.-.beta. cross-linked hemoglobins and method of preparation
The present invention provides a modified hemoglobin comprising hemoglobin which is cross-linked ...


 Substituted iminodiacids, their preparation and pharmaceutical compositions containing them

Details
Inventors: Vincent, Michel; Remond, Georges; Laubie, Michel;
Assignee: Adir (Neuilly-sur-Seine, FR)
Primary Examiner: Daus; Donald G.
Assistant Examiner: Hendricks; G.
Attorney, Agent or Firm: Hueschen; Gordon W.

Compounds of the general formula: ##STR1## wherein: the ring A is saturated and n=0 or 1, or the ring A is a benzene ring and n=1, R.sub.1 represents a lower alkyl group which can carry an amino group, R.sub.2 represents a hydrogen atom or a lower alkyl group, R.sub.3 represents a straight or branched alkyl group, a mono- or di-cycloalkylalkyl or phenylalkyl group having no more than a total of 9 carbon atoms, or a substituted alkyl group, and also the salts thereof. These compounds are useful as therapeutic drugs.

DETAILED DESCRIPTION We claim: 1.
A compound selected from the group consisting of iminodiacid compounds having the formula: ##STR20## wherein R.
sub.
1 represents lower-alkyl having 1 to 4 carbon atoms, inclusive, R.
sub.
2 represents hydrogen or lower-alkyl having 1 to 4 carbon atoms, inclusive, R.
sub.
3 is --CH.
sub.
2 CH.
sub.
2 --CH.
sub.
3, in racemic form or as an optical isomer, a salt thereof with a pharmaceutically-acceptable inorganic or organic base, and an addition salt thereof with a pharmaceutically-acceptable inorganic or organic acid.
2.
A compound of claim 1, in which R.
sub.
1 is a methyl radical.
3.
(2S)-1-{N[(1RS)-1-ethoxycarbonylbutyl]-(S)-alanyl}-2-carboxy perhydroindole, its (S)-isomer or the sodium salt of these.
4.
A pharmaceutical composition containing as active ingredient at least one compound according to claim 1, in conjunction with an inert, non-toxic pharmaceutically-acceptable carrier or excipient.
5.
A pharmaceutical composition containing as active ingredient a compound according to claim 3, in conjunction with an inert, non-toxic pharmaceutically-acceptable carrier or excipient.
6.
A method for treating a patient suffering from hypertension, which comprises administering to said patient a therapeutically effective dose of a compound according to claim 1.
7.
A method for treating a patient suffering from hypertension, which comprises administering to said patient a therapeutically-effective dose of a compound according to claim 3.




Description:
The present invention relates to new substituted imino-diacids, and more particularly to substituted azabicycloalkanedicarboxylic acids, their preparation and pharmaceutical compositions which contain them.
The invention relates specifically to the compounds having the general formula ##STR2## wherein: the ring A is saturated and n=0 or 1, or the ring A is a benzene ring and n=1, R.
sub.
1 represents a lower alkyl group having from 1 to 4 carbon atoms which can carry an amino group, R.
sub.
2 represents a hydrogen atom or an alkyl group having from 1 to 4 carbon atoms, R



Related patents
  2-Azasfiro[4.(3+N)]-3-carboxylic acid derivatives, a process for their preparation, agents containing these derivatives and their use
We claim: 1. A compound of the formula I ##STR11## in which n denotes 1, 2, 3 or 4, R denotes (C.sub.1 -C.sub.6)-alkyl, (C.sub.2 -C.sub.6)-alkenyl, (C.sub.5 -C.sub.9)-...
  N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof
We claim: 1. A compound of the formula I, ##STR24## in which n denotes 0 to 1, R denotes hydrogen, (C.sub.1 to C.sub.6)-alkyl or aralkyl having 7 to 9 C atoms, R.sup.1 ...
  Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
We claim: 1. A compound of the formula III ##STR19## in which A denotes --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --, the H atoms on C-2 and C-6 are in the cis-...
  Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents
OF THE INVENTION AND PREFERRED EMBODIMENTS In its broadest aspect, the present invention relates to novel substituted N-carboxymethyl-aminoacylaminoalkanoic acid ...
  Racemates of optically active bicyclic imino-alpha-carboxylic esters
We claim: 1. A diasteromic salt of i. a bicyclic imino-.alpha.-carboxylic ester of the formulae Ia or Ib ##STR15## in which the two bridgehead hydrogen atoms have the ...
  Disubstituted proline derivatives
We claim: 1. A compound of the formula I ##STR15## in which R.sup.1 and R.sup.2 together represent one of the chains --(CH.sub.2).sub.n -- or --(CH.sub.2).sub.p --CH.dbd....
  Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic acid, and their use for treating hypertension
We claim: 1. A compound of the formula I ##STR11## in which the hydrogen atoms on the bridgehead C atoms 1 and 5 have the cis-configuration relative to one another and ...
  Carboxyalkyl dipeptides and anti-hypertensive use thereof
We claim: 1. A compound represented by the formula ##STR12## and the pharmaceutically acceptable salts thereof, wherein R and R.sup.6 are the same or different and are ...
  Optically active bicyclic imino-alpha-carboxylic esters
We claim: 1. A compound of the formulae Ia or Ib essentially free of its racemate, and salts of said compound, ##STR15## in which the two bridgehead hydrogen atoms have ...
  5-HT.sub.3 receptor antagonists for treatment of cough and bronchoconstriction
I claim: 1. A method of treatment of cough and/or bronchoconstriction in mammals, which method comprises the administration to the mammal in need of such treatment, an ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved